{"id":"NCT02137772","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)","officialTitle":"A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-06","primaryCompletion":"2016-08-08","completion":"2016-11-21","firstPosted":"2014-05-14","resultsPosted":"2017-11-17","lastUpdate":"2019-09-11"},"enrollment":570,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Prevention of CMV Infection or Disease"],"interventions":[{"type":"DRUG","name":"Letermovir","otherNames":["MK-8228"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Letermovir","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study evaluated the efficacy and safety of letermovir (MK-8228) for the prevention of clinically-significant CMV infection in adult, CMV-seropositive recipients of allogeneic hematopoietic stem cell transplant (HSCT). The hypothesis being tested was that MK-8228 is superior to placebo in the prevention of clinically-significant CMV infection through Week 24 post-transplant.","primaryOutcome":{"measure":"Percentage of Participants With Clinically-significant CMV Infection up to Week 24 Post-transplant","timeFrame":"Up to Week 24 post-transplant","effectByArm":[{"arm":"Letermovir","deltaMin":37.5,"sd":null},{"arm":"Placebo","deltaMin":60.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":18},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["34674258","33440077","31179485","29211658"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":202,"n":373},"commonTop":["Graft versus host disease","Diarrhoea","Nausea","Rash","Pyrexia"]}}